🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 10 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/09/2021 46,34 46,54 45,69 46,13 -0,73% 1,83% 163.800
15/09/2021 44,98 47,28 44,46 46,47 +3,13% 6,28% 293.500
14/09/2021 45,39 46,11 45,00 45,06 -0,73% 2,45% 309.100
13/09/2021 45,11 45,70 43,76 45,39 +0,69% 4,30% 293.300
10/09/2021 45,93 46,37 44,73 45,08 -1,62% 3,57% 366.000
09/09/2021 46,20 46,96 45,58 45,82 -1,19% 2,99% 320.100
08/09/2021 48,48 48,48 46,06 46,37 -4,65% 4,99% 342.700
07/09/2021 49,00 50,54 48,51 48,63 -0,51% 4,14% 342.700
03/09/2021 49,45 49,75 48,82 48,88 -1,49% 1,88% 214.800
02/09/2021 49,69 49,90 48,96 49,62 -0,14% 1,89% 265.800
01/09/2021 48,40 49,74 47,95 49,69 +2,45% 3,70% 297.800
31/08/2021 46,95 48,80 46,26 48,50 +3,72% 5,41% 318.500
30/08/2021 47,75 48,47 46,60 46,76 -2,32% 3,91% 232.400
27/08/2021 47,00 48,32 45,77 47,87 +1,53% 5,43% 311.600
26/08/2021 49,05 49,85 47,07 47,15 -3,91% 5,67% 247.600
25/08/2021 49,73 50,00 48,49 49,07 -1,21% 3,04% 155.000
24/08/2021 49,50 49,90 48,38 49,67 +0,16% 3,06% 216.500
23/08/2021 49,60 50,20 48,66 49,59 +0,75% 3,10% 400.200
20/08/2021 48,02 49,82 48,02 49,22 +2,05% 3,75% 315.900
19/08/2021 46,24 48,88 45,91 48,23 +3,36% 6,42% 219.100
18/08/2021 48,02 48,52 46,53 46,66 -3,36% 4,14% 279.000
17/08/2021 47,27 48,50 46,01 48,28 +0,90% 5,27% 182.600
16/08/2021 47,43 48,87 46,75 47,85 +0,34% 4,47% 148.400
13/08/2021 48,49 49,50 47,62 47,69 -1,89% 3,88% 223.100
12/08/2021 47,81 49,29 47,11 48,61 +1,27% 4,56% 250.900
11/08/2021 48,85 49,27 46,54 48,00 -3,23% 5,59% 306.800
10/08/2021 49,08 50,49 47,88 49,60 +1,08% 5,32% 498.200
09/08/2021 47,59 49,15 46,84 49,07 +2,00% 4,84% 290.300
06/08/2021 48,92 49,25 47,27 48,11 -0,17% 4,05% 478.700
05/08/2021 48,79 48,85 46,55 48,19 -1,61% 4,71% 440.800